Soyfood and isoflavone intake and risk of type 2 diabetes in Vietnamese adults

Background/Objectives: Animal studies have demonstrated that soy isoflavones exert antidiabetic effects. However, evidence regarding the association between soyfood intake, a unique source of isoflavones, and type 2 diabetes remains inconclusive. This study assessed the relationship between habitual...

Full description

Saved in:
Bibliographic Details
Published in:European journal of clinical nutrition Vol. 71; no. 10; pp. 1186 - 1192
Main Authors: Nguyen, C T, Pham, N M, Do, V V, Binns, C W, Hoang, V M, Dang, D A, Lee, A H
Format: Journal Article
Language:English
Published: London Nature Publishing Group UK 01.10.2017
Nature Publishing Group
Subjects:
ISSN:0954-3007, 1476-5640, 1476-5640
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Background/Objectives: Animal studies have demonstrated that soy isoflavones exert antidiabetic effects. However, evidence regarding the association between soyfood intake, a unique source of isoflavones, and type 2 diabetes remains inconclusive. This study assessed the relationship between habitual intakes of soyfoods and major isoflavones and risk of type 2 diabetes in Vietnamese adults. Subjects/Methods: A hospital-based case-control study was conducted in Vietnam during 2013–2015. A total of 599 newly diagnosed diabetic cases (age 40–65 years) and 599 hospital-based controls, frequency matched by age and sex, were recruited in Hanoi, capital city of Vietnam. Information on frequency and quantity of soyfood and isoflavone intake, together with demographics, habitual diet and lifestyle characteristics, was obtained from direct interviews using a validated and reliable questionnaire. Unconditional logistic regression analyses were performed to examine the association between soy variables and type 2 diabetes risk. Results: Higher intake of total soyfoods was significantly associated with a lower risk of type 2 diabetes; the adjusted odds ratio (OR) for the highest versus the lowest intake was 0.31 (95% confidence interval (CI): 0.21–0.46; P <0.001). An inverse dose–response relationship of similar magnitude was also observed for total isoflavone intake (OR: 0.35; 95% CI: 0.24 to 0.49; P <0.001). In addition, inverse associations of specific soyfoods (soy milk, tofu and mung bean sprout) and major isoflavones (daidzein, genistein and glycitein) with the type 2 diabetes risk were evident. Conclusions: Soyfood and isoflavone intake was associated with a lower type 2 diabetes risk in Vietnamese adults.
AbstractList Background/Objectives: Animal studies have demonstrated that soy isoflavones exert antidiabetic effects. However, evidence regarding the association between soyfood intake, a unique source of isoflavones, and type 2 diabetes remains inconclusive. This study assessed the relationship between habitual intakes of soyfoods and major isoflavones and risk of type 2 diabetes in Vietnamese adults. Subjects/Methods: A hospital-based case-control study was conducted in Vietnam during 2013-2015. A total of 599 newly diagnosed diabetic cases (age 40-65 years) and 599 hospital-based controls, frequency matched by age and sex, were recruited in Hanoi, capital city of Vietnam. Information on frequency and quantity of soyfood and isoflavone intake, together with demographics, habitual diet and lifestyle characteristics, was obtained from direct interviews using a validated and reliable questionnaire. Unconditional logistic regression analyses were performed to examine the association between soy variables and type 2 diabetes risk. Results: Higher intake of total soyfoods was significantly associated with a lower risk of type 2 diabetes; the adjusted odds ratio (OR) for the highest versus the lowest intake was 0.31 (95% confidence interval (CI): 0.21-0.46; P<0.001). An inverse dose-response relationship of similar magnitude was also observed for total isoflavone intake (OR: 0.35; 95% CI: 0.24 to 0.49; P<0.001). In addition, inverse associations of specific soyfoods (soy milk, tofu and mung bean sprout) and major isoflavones (daidzein, genistein and glycitein) with the type 2 diabetes risk were evident. Conclusions: Soyfood and isoflavone intake was associated with a lower type 2 diabetes risk in Vietnamese adults.
Background/Objectives: Animal studies have demonstrated that soy isoflavones exert antidiabetic effects. However, evidence regarding the association between soyfood intake, a unique source of isoflavones, and type 2 diabetes remains inconclusive. This study assessed the relationship between habitual intakes of soyfoods and major isoflavones and risk of type 2 diabetes in Vietnamese adults. Subjects/Methods: A hospital-based case-control study was conducted in Vietnam during 2013-2015. A total of 599 newly diagnosed diabetic cases (age 40-65 years) and 599 hospital-based controls, frequency matched by age and sex, were recruited in Hanoi, capital city of Vietnam. Information on frequency and quantity of soyfood and isoflavone intake, together with demographics, habitual diet and lifestyle characteristics, was obtained from direct interviews using a validated and reliable questionnaire. Unconditional logistic regression analyses were performed to examine the association between soy variables and type 2 diabetes risk. Results: Higher intake of total soyfoods was significantly associated with a lower risk of type 2 diabetes; the adjusted odds ratio (OR) for the highest versus the lowest intake was 0.31 (95% confidence interval (CI): 0.21-0.46; P [less than] 0.001). An inverse dose-response relationship of similar magnitude was also observed for total isoflavone intake (OR: 0.35; 95% CI: 0.24 to 0.49; P [less than] 0.001). In addition, inverse associations of specific soyfoods (soy milk, tofu and mung bean sprout) and major isoflavones (daidzein, genistein and glycitein) with the type 2 diabetes risk were evident. Conclusions: Soyfood and isoflavone intake was associated with a lower type 2 diabetes risk in Vietnamese adults. European Journal of Clinical Nutrition (2017) 71, 1186-1192; doi: 10.1038/ejcn.2017.76; published online 10 May 2017
Animal studies have demonstrated that soy isoflavones exert antidiabetic effects. However, evidence regarding the association between soyfood intake, a unique source of isoflavones, and type 2 diabetes remains inconclusive. This study assessed the relationship between habitual intakes of soyfoods and major isoflavones and risk of type 2 diabetes in Vietnamese adults. Higher intake of total soyfoods was significantly associated with a lower risk of type 2 diabetes; the adjusted odds ratio (OR) for the highest versus the lowest intake was 0.31 (95% confidence interval (CI): 0.21-0.46; P [less than] 0.001). An inverse dose-response relationship of similar magnitude was also observed for total isoflavone intake (OR: 0.35; 95% CI: 0.24 to 0.49; P [less than] 0.001). In addition, inverse associations of specific soyfoods (soy milk, tofu and mung bean sprout) and major isoflavones (daidzein, genistein and glycitein) with the type 2 diabetes risk were evident. Soyfood and isoflavone intake was associated with a lower type 2 diabetes risk in Vietnamese adults.
Animal studies have demonstrated that soy isoflavones exert antidiabetic effects. However, evidence regarding the association between soyfood intake, a unique source of isoflavones, and type 2 diabetes remains inconclusive. This study assessed the relationship between habitual intakes of soyfoods and major isoflavones and risk of type 2 diabetes in Vietnamese adults. A hospital-based case-control study was conducted in Vietnam during 2013-2015. A total of 599 newly diagnosed diabetic cases (age 40-65 years) and 599 hospital-based controls, frequency matched by age and sex, were recruited in Hanoi, capital city of Vietnam. Information on frequency and quantity of soyfood and isoflavone intake, together with demographics, habitual diet and lifestyle characteristics, was obtained from direct interviews using a validated and reliable questionnaire. Unconditional logistic regression analyses were performed to examine the association between soy variables and type 2 diabetes risk. Higher intake of total soyfoods was significantly associated with a lower risk of type 2 diabetes; the adjusted odds ratio (OR) for the highest versus the lowest intake was 0.31 (95% confidence interval (CI): 0.21-0.46; P<0.001). An inverse dose-response relationship of similar magnitude was also observed for total isoflavone intake (OR: 0.35; 95% CI: 0.24 to 0.49; P<0.001). In addition, inverse associations of specific soyfoods (soy milk, tofu and mung bean sprout) and major isoflavones (daidzein, genistein and glycitein) with the type 2 diabetes risk were evident. Soyfood and isoflavone intake was associated with a lower type 2 diabetes risk in Vietnamese adults.
Background/Objectives: Animal studies have demonstrated that soy isoflavones exert antidiabetic effects. However, evidence regarding the association between soyfood intake, a unique source of isoflavones, and type 2 diabetes remains inconclusive. This study assessed the relationship between habitual intakes of soyfoods and major isoflavones and risk of type 2 diabetes in Vietnamese adults. Subjects/Methods: A hospital-based case-control study was conducted in Vietnam during 2013–2015. A total of 599 newly diagnosed diabetic cases (age 40–65 years) and 599 hospital-based controls, frequency matched by age and sex, were recruited in Hanoi, capital city of Vietnam. Information on frequency and quantity of soyfood and isoflavone intake, together with demographics, habitual diet and lifestyle characteristics, was obtained from direct interviews using a validated and reliable questionnaire. Unconditional logistic regression analyses were performed to examine the association between soy variables and type 2 diabetes risk. Results: Higher intake of total soyfoods was significantly associated with a lower risk of type 2 diabetes; the adjusted odds ratio (OR) for the highest versus the lowest intake was 0.31 (95% confidence interval (CI): 0.21–0.46; P <0.001). An inverse dose–response relationship of similar magnitude was also observed for total isoflavone intake (OR: 0.35; 95% CI: 0.24 to 0.49; P <0.001). In addition, inverse associations of specific soyfoods (soy milk, tofu and mung bean sprout) and major isoflavones (daidzein, genistein and glycitein) with the type 2 diabetes risk were evident. Conclusions: Soyfood and isoflavone intake was associated with a lower type 2 diabetes risk in Vietnamese adults.
Animal studies have demonstrated that soy isoflavones exert antidiabetic effects. However, evidence regarding the association between soyfood intake, a unique source of isoflavones, and type 2 diabetes remains inconclusive. This study assessed the relationship between habitual intakes of soyfoods and major isoflavones and risk of type 2 diabetes in Vietnamese adults. Higher intake of total soyfoods was significantly associated with a lower risk of type 2 diabetes; the adjusted odds ratio (OR) for the highest versus the lowest intake was 0.31 (95% confidence interval (CI): 0.21-0.46; P<0.001). An inverse dose-response relationship of similar magnitude was also observed for total isoflavone intake (OR: 0.35; 95% CI: 0.24 to 0.49; P<0.001). In addition, inverse associations of specific soyfoods (soy milk, tofu and mung bean sprout) and major isoflavones (daidzein, genistein and glycitein) with the type 2 diabetes risk were evident. Soyfood and isoflavone intake was associated with a lower type 2 diabetes risk in Vietnamese adults.
Animal studies have demonstrated that soy isoflavones exert antidiabetic effects. However, evidence regarding the association between soyfood intake, a unique source of isoflavones, and type 2 diabetes remains inconclusive. This study assessed the relationship between habitual intakes of soyfoods and major isoflavones and risk of type 2 diabetes in Vietnamese adults.BACKGROUND/OBJECTIVESAnimal studies have demonstrated that soy isoflavones exert antidiabetic effects. However, evidence regarding the association between soyfood intake, a unique source of isoflavones, and type 2 diabetes remains inconclusive. This study assessed the relationship between habitual intakes of soyfoods and major isoflavones and risk of type 2 diabetes in Vietnamese adults.A hospital-based case-control study was conducted in Vietnam during 2013-2015. A total of 599 newly diagnosed diabetic cases (age 40-65 years) and 599 hospital-based controls, frequency matched by age and sex, were recruited in Hanoi, capital city of Vietnam. Information on frequency and quantity of soyfood and isoflavone intake, together with demographics, habitual diet and lifestyle characteristics, was obtained from direct interviews using a validated and reliable questionnaire. Unconditional logistic regression analyses were performed to examine the association between soy variables and type 2 diabetes risk.SUBJECTS/METHODSA hospital-based case-control study was conducted in Vietnam during 2013-2015. A total of 599 newly diagnosed diabetic cases (age 40-65 years) and 599 hospital-based controls, frequency matched by age and sex, were recruited in Hanoi, capital city of Vietnam. Information on frequency and quantity of soyfood and isoflavone intake, together with demographics, habitual diet and lifestyle characteristics, was obtained from direct interviews using a validated and reliable questionnaire. Unconditional logistic regression analyses were performed to examine the association between soy variables and type 2 diabetes risk.Higher intake of total soyfoods was significantly associated with a lower risk of type 2 diabetes; the adjusted odds ratio (OR) for the highest versus the lowest intake was 0.31 (95% confidence interval (CI): 0.21-0.46; P<0.001). An inverse dose-response relationship of similar magnitude was also observed for total isoflavone intake (OR: 0.35; 95% CI: 0.24 to 0.49; P<0.001). In addition, inverse associations of specific soyfoods (soy milk, tofu and mung bean sprout) and major isoflavones (daidzein, genistein and glycitein) with the type 2 diabetes risk were evident.RESULTSHigher intake of total soyfoods was significantly associated with a lower risk of type 2 diabetes; the adjusted odds ratio (OR) for the highest versus the lowest intake was 0.31 (95% confidence interval (CI): 0.21-0.46; P<0.001). An inverse dose-response relationship of similar magnitude was also observed for total isoflavone intake (OR: 0.35; 95% CI: 0.24 to 0.49; P<0.001). In addition, inverse associations of specific soyfoods (soy milk, tofu and mung bean sprout) and major isoflavones (daidzein, genistein and glycitein) with the type 2 diabetes risk were evident.Soyfood and isoflavone intake was associated with a lower type 2 diabetes risk in Vietnamese adults.CONCLUSIONSSoyfood and isoflavone intake was associated with a lower type 2 diabetes risk in Vietnamese adults.
Audience Professional
Academic
Author Do, V V
Dang, D A
Binns, C W
Pham, N M
Nguyen, C T
Lee, A H
Hoang, V M
Author_xml – sequence: 1
  givenname: C T
  surname: Nguyen
  fullname: Nguyen, C T
  organization: School of Public Health, Curtin University, National Institute of Hygiene and Epidemiology
– sequence: 2
  givenname: N M
  surname: Pham
  fullname: Pham, N M
  organization: School of Public Health, Curtin University, Thai Nguyen University of Medicine and Pharmacy
– sequence: 3
  givenname: V V
  surname: Do
  fullname: Do, V V
  organization: School of Public Health, Curtin University
– sequence: 4
  givenname: C W
  surname: Binns
  fullname: Binns, C W
  organization: School of Public Health, Curtin University
– sequence: 5
  givenname: V M
  surname: Hoang
  fullname: Hoang, V M
  organization: Hanoi University of Public Health
– sequence: 6
  givenname: D A
  surname: Dang
  fullname: Dang, D A
  organization: National Institute of Hygiene and Epidemiology
– sequence: 7
  givenname: A H
  surname: Lee
  fullname: Lee, A H
  email: Andy.Lee@curtin.edu.au
  organization: School of Public Health, Curtin University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28488690$$D View this record in MEDLINE/PubMed
BookMark eNqNk8lrGzEUxkVJaJy0t57LQCH00HG1jZZjCF0CoT10uQpJo3HkjCV3pCn4v6-mcagTXBN0EEi_972Pt5yCoxCDA-AVgnMEiXjvljbMMUR8ztkzMEOUs7phFB6BGZQNrQmE_AScprSEsHxy_BycYEGFYBLOwJdvcdPF2FY6tJVPsev176Jf-ZD1rfv7Ovh0W8Wuypu1q3DVem1cdqkg1U_vctArlwrZjn1OL8Bxp_vkXm7vM_Dj44fvl5_r66-fri4vrmvLMcm1plRghhpCrLHWUm0YFYgxZDptOoexxkYi0hlqDaFYMGNNw6SgLWmsxJycgbd3uush_hpdymrlk3V9r4OLY1JISFmqw7go6JtH6DKOQyju1GSheBCEHKKQpAxzWuz9oxa6d8qHLuZB2ym1umBCYtHI5jDVQC6JhBIWqt5DLVxwg-5LCzpfnh-oPoXf1Z_v4ctp3crbvQmeFLCb4Xwn4MbpPt-k2I_Zx5AeKh8EdxVfb7swmpVr1XrwKz1s1P28FgDfAXaIKQ2uU9ZnPekUr75XCKppKdS0FGpaCsWn9O8eBd3r_gffFjoVLCzcsDMK-_g_BO8VEw
CitedBy_id crossref_primary_10_1089_jmf_2017_0084
crossref_primary_10_1177_1043659620988317
crossref_primary_10_1016_j_nupar_2020_02_437
crossref_primary_10_1080_87559129_2022_2043894
crossref_primary_10_2174_0929867325666180926152139
crossref_primary_10_1093_advances_nmab121
crossref_primary_10_3390_nu17020275
crossref_primary_10_1016_j_advnut_2024_100210
crossref_primary_10_1016_j_nutres_2018_06_005
crossref_primary_10_3390_nu11071660
crossref_primary_10_1093_ajcn_nqy083
crossref_primary_10_3389_fnut_2021_813742
crossref_primary_10_1016_j_nutres_2019_03_015
crossref_primary_10_1007_s00394_020_02189_1
crossref_primary_10_1002_biof_1439
crossref_primary_10_3390_nu15061358
crossref_primary_10_3390_foods11233905
Cites_doi 10.1016/S0140-6736(16)00618-8
10.1038/srep23075
10.1002/sim.4780080504
10.2337/dc16-0654
10.1016/j.jnutbio.2009.06.012
10.1016/j.bmc.2003.11.035
10.3945/jn.109.116020
10.1007/s12020-014-0264-4
10.4239/wjd.v6.i2.271
10.1007/s00125-014-3463-x
10.1093/ajcn/65.4.1220S
10.1038/sj.ejcn.1601855
10.1186/s40064-016-2313-3
10.1001/jama.2013.284427
10.1038/nbt.2942
10.1017/S0007114516000581
10.1017/S0007114515003359
10.1079/BJN2002796
10.1016/j.bcp.2014.07.018
10.1016/j.lfs.2006.03.022
10.1038/ejcn.2016.117
10.1093/jn/137.4.1011
10.1038/ejcn.2010.228
10.1111/j.1753-4887.2012.00492.x
10.1207/s15327914nc5501_1
10.1001/jama.295.11.1288
10.1111/jdi.12100
10.3945/jn.109.119776
10.2337/dc14-3093
10.1021/jf034427b
10.1097/00001648-199103000-00008
10.1017/S136898001400247X
10.3945/ajcn.110.007187
10.1016/j.nutres.2009.11.004
10.1007/s00394-011-0276-2
10.1002/ijc.11165
10.1016/S1570-0232(02)00342-2
10.1093/ajcn/87.1.162
10.2337/dc13-0877
10.1177/1010539515595860
10.1177/1536867X0800800103
10.1093/ajcn/68.6.1333S
ContentType Journal Article
Copyright Macmillan Publishers Limited, part of Springer Nature. 2017
COPYRIGHT 2017 Nature Publishing Group
Copyright Nature Publishing Group Oct 2017
Macmillan Publishers Limited, part of Springer Nature. 2017.
Copyright_xml – notice: Macmillan Publishers Limited, part of Springer Nature. 2017
– notice: COPYRIGHT 2017 Nature Publishing Group
– notice: Copyright Nature Publishing Group Oct 2017
– notice: Macmillan Publishers Limited, part of Springer Nature. 2017.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QP
7RV
7TK
7X2
7X7
7XB
88E
8AO
8C1
8FE
8FH
8FI
8FJ
8FK
8G5
ABUWG
AEUYN
AFKRA
AN0
ATCPS
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
GUQSH
HCIFZ
K9.
KB0
LK8
M0K
M0S
M1P
M2O
M7P
MBDVC
NAPCQ
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
7X8
DOI 10.1038/ejcn.2017.76
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Calcium & Calcified Tissue Abstracts
Nursing & Allied Health Database
Neurosciences Abstracts
Agricultural Science Collection
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Public Health Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Research Library (Alumni)
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
British Nursing Database
Agricultural & Environmental Science Collection
ProQuest Central Essentials
Biological Science Collection
ProQuest Central Database Suite (ProQuest)
Natural Science Collection
ProQuest One
ProQuest Central
Proquest Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
ProQuest Research Library
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
Biological Sciences
Agriculture Science Database
ProQuest Health & Medical Collection
Medical Database
ProQuest Research Library
Biological Science Database
Research Library (Corporate)
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Agricultural Science Database
Research Library Prep
ProQuest Central Student
ProQuest Central Essentials
SciTech Premium Collection
ProQuest Central China
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Health Research Premium Collection
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
Agricultural Science Collection
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest One Academic (New)
ProQuest One Academic Middle East (New)
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
Research Library (Alumni Edition)
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central
ProQuest Health & Medical Research Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Agricultural & Environmental Science Collection
ProQuest Research Library
ProQuest Public Health
ProQuest Central Basic
British Nursing Index with Full Text
ProQuest Nursing & Allied Health Source
ProQuest SciTech Collection
ProQuest Medical Library
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList



MEDLINE

Agricultural Science Database



Agricultural Science Database

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Public Health
Anatomy & Physiology
Diet & Clinical Nutrition
EISSN 1476-5640
EndPage 1192
ExternalDocumentID A689285956
A507939090
28488690
10_1038_ejcn_2017_76
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations Vietnam
GeographicLocations_xml – name: Vietnam
GroupedDBID ---
-ET
-Q-
.GJ
0R~
29G
2WC
36B
39C
4.4
406
53G
5GY
5RE
6PF
70F
7RV
7X2
7X7
88E
8AO
8C1
8FE
8FH
8FI
8FJ
8G5
8R4
8R5
A8Z
AACDK
AAHBH
AAIKC
AAMNW
AANZL
AASML
AATNV
AAWTL
AAYZH
ABAKF
ABAWZ
ABBRH
ABCQX
ABDBE
ABDBF
ABFSG
ABJNI
ABLJU
ABOCM
ABRTQ
ABUWG
ABZZP
ACAOD
ACGFO
ACGFS
ACKTT
ACMJI
ACPRK
ACRQY
ACSTC
ACUHS
ACZOJ
ADBBV
ADFRT
ADHUB
AEFQL
AEJRE
AEMSY
AENEX
AEUYN
AEVLU
AEXYK
AEZWR
AFBBN
AFDZB
AFHIU
AFKRA
AFRAH
AFSHS
AGAYW
AGHAI
AGQEE
AHMBA
AHSBF
AHWEU
AI.
AIGIU
AILAN
AIXLP
AJRNO
ALFFA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMYLF
AN0
APEBS
ATCPS
ATHPR
AXYYD
AYFIA
AZQEC
B0M
BAWUL
BBNVY
BENPR
BHPHI
BKEYQ
BKKNO
BKOMP
BNQBC
BPHCQ
BVXVI
CCPQU
CS3
DIK
DNIVK
DPUIP
DU5
DWQXO
E.L
E3Z
EAD
EAP
EAS
EBC
EBD
EBLON
EBO
EBS
ECGQY
EE.
EHN
EIHBH
EIOEI
EJD
EMB
EMK
EMOBN
EPL
EPT
ESX
EX3
F5P
FDQFY
FERAY
FIGPU
FIZPM
FSGXE
FYUFA
GNUQQ
GUQSH
HCIFZ
HMCUK
HZ~
IAG
IAO
ICU
IEA
IHR
IHT
IHW
INH
INR
IOF
ITC
IWAJR
JSO
JZLTJ
KQ8
LGEZI
LOTEE
M0K
M1P
M2O
M7P
NADUK
NAPCQ
NQJWS
NXXTH
O9-
OK1
OVD
P2P
PHGZM
PHGZT
PJZUB
PPXIY
PQGLB
PQQKQ
PROAC
PSQYO
Q2X
Q~Q
RNS
RNT
RNTTT
ROL
RXW
SNX
SNYQT
SOHCF
SOJ
SRMVM
SV3
SWTZT
TAE
TAOOD
TBHMF
TDRGL
TEORI
TH9
TR2
TSG
TUS
UKHRP
VH1
WH7
WOW
XOL
ZXP
~02
~8M
~KM
AAYXX
AFFHD
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
ACMFV
3V.
7QP
7TK
7XB
8FK
ESTFP
K9.
LK8
MBDVC
PKEHL
PQEST
PQUKI
PRINS
Q9U
7X8
PUEGO
ID FETCH-LOGICAL-c723t-a448261533cbccc4ab6481661bfabfe22a2b913fb4cb34286bcb56984d35c9273
IEDL.DBID M7P
ISICitedReferencesCount 23
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000412202800007&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 0954-3007
1476-5640
IngestDate Mon Sep 08 05:28:18 EDT 2025
Fri Oct 03 09:50:11 EDT 2025
Fri Oct 03 08:20:50 EDT 2025
Sat Nov 29 13:04:15 EST 2025
Sat Nov 29 13:28:03 EST 2025
Sat Nov 29 11:15:09 EST 2025
Sat Nov 29 11:38:30 EST 2025
Sat Nov 29 09:53:18 EST 2025
Sun Nov 23 08:53:42 EST 2025
Thu May 22 21:08:47 EDT 2025
Thu May 22 21:14:35 EDT 2025
Thu Apr 03 07:01:40 EDT 2025
Tue Nov 18 21:03:50 EST 2025
Sat Nov 29 05:00:56 EST 2025
Mon Jul 21 06:06:59 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 10
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c723t-a448261533cbccc4ab6481661bfabfe22a2b913fb4cb34286bcb56984d35c9273
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMID 28488690
PQID 1946274166
PQPubID 33883
PageCount 7
ParticipantIDs proquest_miscellaneous_1899103678
proquest_journals_2615533833
proquest_journals_1946274166
gale_infotracmisc_A689285956
gale_infotracmisc_A507939090
gale_infotracgeneralonefile_A689285956
gale_infotracgeneralonefile_A507939090
gale_infotracacademiconefile_A689285956
gale_infotracacademiconefile_A507939090
gale_healthsolutions_A689285956
gale_healthsolutions_A507939090
pubmed_primary_28488690
crossref_citationtrail_10_1038_ejcn_2017_76
crossref_primary_10_1038_ejcn_2017_76
springer_journals_10_1038_ejcn_2017_76
PublicationCentury 2000
PublicationDate 2017-10-01
PublicationDateYYYYMMDD 2017-10-01
PublicationDate_xml – month: 10
  year: 2017
  text: 2017-10-01
  day: 01
PublicationDecade 2010
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle European journal of clinical nutrition
PublicationTitleAbbrev Eur J Clin Nutr
PublicationTitleAlternate Eur J Clin Nutr
PublicationYear 2017
Publisher Nature Publishing Group UK
Nature Publishing Group
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
References SetchellKDPhytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavonesAm J Clin Nutr1998681333S1346S1:CAS:528:DyaK1cXnvV2gsb4%3D10.1093/ajcn/68.6.1333S
LiJJiaHCaiXZhongHFengQSunagawaSAn integrated catalog of reference genes in the human gut microbiomeNat Biotechnol2014328348411:CAS:528:DC%2BC2cXhtFSlsLjP10.1038/nbt.2942
TatsumiYMorimotoADeuraKMizunoSOhnoYWatanabeSEffects of soybean product intake on fasting and postload hyperglycemia and type 2 diabetes in Japanese men with high body mass index: The Saku StudyJ Diabetes Investig201346266331:CAS:528:DC%2BC3sXhvVOitL3I10.1111/jdi.12100
KwonDYDailyJW3rdKimHJParkSAntidiabetic effects of fermented soybean products on type 2 diabetesNutr Res2010301131:CAS:528:DC%2BC3cXhtVKitrs%3D10.1016/j.nutres.2009.11.004
WillettWCHoweGRKushiLHAdjustment for total energy intake in epidemiologic studiesAm J Clin Nutr1997651220S1228S1:CAS:528:DyaK2sXitlamu70%3D10.1093/ajcn/65.4.1220S
YangGShuXOJinFElasyTLiHLLiQSoyfood consumption and risk of glycosuria: a cross-sectional study within the Shanghai Women's Health StudyEur J Clin Nutr2004586156201:STN:280:DC%2BD2c7kvVCrsg%3D%3D10.1038/sj.ejcn.1601855
OrsiniNBelloccoRA tool for deterministic and probabilistic sensitivity analysis of epidemiologic studiesStat J20088294810.1177/1536867X0800800103
ChenLZhangYHHuangTCaiYDGene expression profiling gut microbiota in different races of humansSci Rep20166230751:CAS:528:DC%2BC28XktlKjtL0%3D10.1038/srep23075
OzenAEPonsATurJAWorldwide consumption of functional foods: a systematic reviewNutr Rev20127047248110.1111/j.1753-4887.2012.00492.x
N. C. D. Risk Factor CollaborationWorldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participantsLancet20163871513153010.1016/S0140-6736(16)00618-8
MurphyPABaruaKHauckCCSolvent extraction selection in the determination of isoflavones in soy foodsJ Chromatogr B Analyt Technol Biomed Life Sci20027771291381:CAS:528:DC%2BD38Xos1Wrtb4%3D10.1016/S1570-0232(02)00342-2
MuellerNTOdegaardAOGrossMDKohWPYuMCYuanJMSoy intake and risk of type 2 diabetes in Chinese SingaporeansEur J Nutr201251103310401:CAS:528:DC%2BC38Xhs12is7vN10.1007/s00394-011-0276-2
TalaeiMPanARole of phytoestrogens in prevention and management of type 2 diabetesWorld J Diabetes2015627128310.4239/wjd.v6.i2.271
LeeSAWenWXiangYBBarnesSLiuDCaiQAssessment of dietary isoflavone intake among middle-aged Chinese menJ Nutr20071371011101610.1093/jn/137.4.1011
MuthyalaRSJuYHShengSWilliamsLDDoergeDRKatzenellenbogenBSEquol, a natural estrogenic metabolite from soy isoflavones: convenient preparation and resolution of R- and S-equols and their differing binding and biological activity through estrogen receptors alpha and betaBioorg Med Chem200412155915671:CAS:528:DC%2BD2cXhslSrsb4%3D10.1016/j.bmc.2003.11.035
SetchellKDClericiCEquol: history, chemistry, and formationJ Nutr20101401355S1362S1:CAS:528:DC%2BC3cXot1agtbk%3D10.3945/jn.109.119776
TalaeiMLeeBLOngCNvan DamRMYuanJMKohWPUrine phyto-oestrogen metabolites are not significantly associated with risk of type 2 diabetes: the Singapore Chinese health studyBr J Nutr2016115160716151:CAS:528:DC%2BC28XnsFWhs70%3D10.1017/S0007114516000581
NanriAMizoueTTakahashiYKiriiKInoueMNodaMSoy product and isoflavone intakes are associated with a lower risk of type 2 diabetes in overweight Japanese womenJ Nutr20101405805861:CAS:528:DC%2BC3cXnsFKhtrk%3D10.3945/jn.109.116020
PhamNMEgglestonKDiabetes prevalence and risk factors among Vietnamese adults: findings from community-based screening programsDiabetes Care201538e77e7810.2337/dc14-3093
KoKPKimCSAhnYParkSJKimYJParkJKPlasma isoflavone concentration is associated with decreased risk of type 2 diabetes in Korean women but not men: results from the Korean Genome and Epidemiology StudyDiabetologia2015587267351:CAS:528:DC%2BC2cXitFOgurfF10.1007/s00125-014-3463-x
DingELSongYMalikVSLiuSSex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysisJAMA2006295128812991:CAS:528:DC%2BD28Xis1ShsLs%3D10.1001/jama.295.11.1288
Ae ParkSChoiMSChoSYSeoJSJungUJKimMJGenistein and daidzein modulate hepatic glucose and lipid regulating enzyme activities in C57BL/KsJ-db/db miceLife Sci2006791207121310.1016/j.lfs.2006.03.022
ZhangMLeeAHBinnsCWPhysical activity and epithelial ovarian cancer risk: a case-control study in ChinaInt J Cancer20031058388431:CAS:528:DC%2BD3sXltVSisb8%3D10.1002/ijc.11165
NakamotoMUemuraHSakaiTKatsuura-KamanoSYamaguchiMHiyoshiMInverse association between soya food consumption and insulin resistance in Japanese adultsPublic Health Nutr2015182031204010.1017/S136898001400247X
VillegasRGaoY-TYangGLiH-LElasyTAZhengWLegume and soy food intake and the incidence of type 2 diabetes in the Shanghai Women's Health StudyAm J Clin Nutr2008871621671:CAS:528:DC%2BD1cXmt1amtg%3D%3D10.1093/ajcn/87.1.162
JamesPAOparilSCarterBLCushmanWCDennison-HimmelfarbCHandlerJ2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)JAMA20143115075201:CAS:528:DC%2BC2cXis1aktr8%3D10.1001/jama.2013.284427
EspositoKChiodiniPMaiorinoMIBellastellaGPanagiotakosDGiuglianoDWhich diet for prevention of type 2 diabetes? A meta-analysis of prospective studiesEndocrine2014471071161:CAS:528:DC%2BC2cXmsVCis7c%3D10.1007/s12020-014-0264-4
NguyenCTPhamNMTranDVLeeAHBinnsCWLifestyle and diet in relation to risk of type 2 diabetes in Vietnam: a hospital-based case-control studySpringerplus2016568710.1186/s40064-016-2313-3
ChoKWLeeOHBanzWJMoustaid-MoussaNShayNFKimYCDaidzein and the daidzein metabolite, equol, enhance adipocyte differentiation and PPARgamma transcriptional activityJ Nutr Biochem2010218418471:CAS:528:DC%2BC3cXhtVKgsbzK10.1016/j.jnutbio.2009.06.012
Zamora-RosRForouhiNGSharpSJGonzalezCABuijsseBGuevaraMThe association between dietary flavonoid and lignan intakes and incident type 2 diabetes in European populations: the EPIC-InterAct studyDiabetes Care201336396139701:CAS:528:DC%2BC3sXhvFaksLrM10.2337/dc13-0877
HsiehCCMaisonneuvePBoylePMacfarlaneGJRoberstonCAnalysis of quantitative data by quantiles in epidemiologic studies: classification according to cases, noncases, or all subjects?Epidemiology199121371401:STN:280:DyaK38%2FjtF2muw%3D%3D10.1097/00001648-199103000-00008
DurrlemanSSimonRFlexible regression models with cubic splinesStat Med198985515611:STN:280:DyaL1M3ms1artg%3D%3D10.1002/sim.4780080504
MessinaMNagataCWuAHEstimated Asian adult soy protein and isoflavone intakesNutr Cancer2006551121:CAS:528:DC%2BD28XhtFakurbP10.1207/s15327914nc5501_1
BhagwatSHaytowitzDBHoldenJMUSDA Database for the isoflavone Content of Selected Foods Release 2.02008US Department of Agriculture: Maryland
GreenlandSLashTLBias analysisModern Epidemiology2008Lippincott–Raven: Philadelphia
Huong NT, Ward M Vietnam oilseeds and products soybean meal and vegetable oil update. GAIN Report Number: VM5019 (2015).
The World Health Organization Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia. Report of a WHO/IDF consultation: Geneva, 2006.
NguyenCTPhamNMLeeAHBinnsCWPrevalence of and risk factors for type 2 diabetes mellitus in Vietnam: a systematic reviewAsia Pac J Public Health20152758860010.1177/1010539515595860
MorimotoYSteinbrecherAKolonelLNMaskarinecGSoy consumption is not protective against diabetes in Hawaii: The Multiethnic CohortEur J Clin Nutr2011652792821:STN:280:DC%2BC3M7lvFKgug%3D%3D10.1038/ejcn.2010.228
WangLWaltenbergerBPferschy-WenzigEMBlunderMLiuXMalainerCNatural product agonists of peroxisome proliferator-activated receptor gamma (PPARgamma): a reviewBiochem Pharmacol20149273891:CAS:528:DC%2BC2cXht1ymtbjK10.1016/j.bcp.2014.07.018
KostelacDRechkemmerGBrivibaKPhytoestrogens modulate binding response of estrogen receptors alpha and beta to the estrogen response elementJ Agric Food Chem200351763276351:CAS:528:DC%2BD3sXovVOhtL4%3D10.1021/jf034427b
LiuZMChenYMHoSCEffects of soy intake on glycemic control: a meta-analysis of randomized controlled trialsAm J Clin Nutr201193109211011:CAS:528:DC%2BC3MXltlCqtr0%3D10.3945/ajcn.110.007187
RowlandIFaughnanMHoeyLWahalaKWilliamsonGCassidyABioavailability of phyto-oestrogensBr J Nutr200389Suppl 1S45S581:CAS:528:DC%2BD3sXltFentrg%3D12725656
DingMFrankeAARosnerBAGiovannucciEvan DamRMTworogerSSUrinary isoflavonoids and risk of type 2 diabetes: a prospective investigation in US womenBr J Nutr2015114169417011:CAS:528:DC%2BC2MXhs1yltLnJ10.1017/S0007114515003359
World Health Organization STEPwise approach to surveillance, 2002. Available at http://www.who.int/chp/steps/en/ (accessed 20 October 2016).
Van TranDVan HoangDNguyenCTLeeAHValidity and reliability of a food frequency questionnaire to assess habitual dietary intake in Northern VietnamVietnam J Pub Health201315764
DingMPanAMansonJEWillettWCMalikVRosnerBConsumption of soy foods and isoflavones and risk of type 2 diabetes: a pooled analysis of three US cohortsEur J Clin Nutr201670138113871:CAS:528:DC%2BC28XhtFGjsLzF10.1038/ejcn.2016.117
Ho-PhamLTDoTTCampbellLVNguyenTVHbA1c-based classification reveals epidemic of diabetes and prediabetes in VietnamDiabetes Care201639e93e9410.2337/dc16-0654
International Diabetes Federation IDF Diabetes Atlas 2015.
InbarajBSChenBHIsoflavone ingestion by multiethnic populations: implications for healthIsoflavones: Chemistry, Analysis, Function and Effects2013RSC Publishing: Cambridge349364
NM Pham (BFejcn201776_CR20) 2015; 38
S Durrleman (BFejcn201776_CR31) 1989; 8
SA Lee (BFejcn201776_CR37) 2007; 137
A Nanri (BFejcn201776_CR10) 2010; 140
G Yang (BFejcn201776_CR33) 2004; 58
M Messina (BFejcn201776_CR5) 2006; 55
Y Morimoto (BFejcn201776_CR13) 2011; 65
D Van Tran (BFejcn201776_CR24) 2013; 1
I Rowland (BFejcn201776_CR39) 2003; 89
R Villegas (BFejcn201776_CR9) 2008; 87
M Ding (BFejcn201776_CR14) 2016; 70
AE Ozen (BFejcn201776_CR17) 2012; 70
BS Inbaraj (BFejcn201776_CR18) 2013
PA James (BFejcn201776_CR29) 2014; 311
KD Setchell (BFejcn201776_CR38) 1998; 68
M Talaei (BFejcn201776_CR6) 2015; 6
BFejcn201776_CR21
R Zamora-Ros (BFejcn201776_CR15) 2013; 36
M Nakamoto (BFejcn201776_CR34) 2015; 18
BFejcn201776_CR28
BFejcn201776_CR1
M Talaei (BFejcn201776_CR35) 2016; 115
BFejcn201776_CR23
L Chen (BFejcn201776_CR40) 2016; 6
CT Nguyen (BFejcn201776_CR19) 2015; 27
CC Hsieh (BFejcn201776_CR30) 1991; 2
S Bhagwat (BFejcn201776_CR25) 2008
D Kostelac (BFejcn201776_CR45) 2003; 51
N Orsini (BFejcn201776_CR49) 2008; 8
WC Willett (BFejcn201776_CR26) 1997; 65
S Ae Park (BFejcn201776_CR43) 2006; 79
LT Ho-Pham (BFejcn201776_CR50) 2016; 39
Y Tatsumi (BFejcn201776_CR12) 2013; 4
KD Setchell (BFejcn201776_CR42) 2010; 140
CT Nguyen (BFejcn201776_CR22) 2016; 5
N. C. D. Risk Factor Collaboration (BFejcn201776_CR2) 2016; 387
NT Mueller (BFejcn201776_CR11) 2012; 51
M Zhang (BFejcn201776_CR27) 2003; 105
PA Murphy (BFejcn201776_CR4) 2002; 777
M Ding (BFejcn201776_CR16) 2015; 114
RS Muthyala (BFejcn201776_CR46) 2004; 12
EL Ding (BFejcn201776_CR47) 2006; 295
K Esposito (BFejcn201776_CR3) 2014; 47
KW Cho (BFejcn201776_CR8) 2010; 21
DY Kwon (BFejcn201776_CR7) 2010; 30
S Greenland (BFejcn201776_CR48) 2008
KP Ko (BFejcn201776_CR32) 2015; 58
ZM Liu (BFejcn201776_CR36) 2011; 93
J Li (BFejcn201776_CR41) 2014; 32
L Wang (BFejcn201776_CR44) 2014; 92
References_xml – reference: VillegasRGaoY-TYangGLiH-LElasyTAZhengWLegume and soy food intake and the incidence of type 2 diabetes in the Shanghai Women's Health StudyAm J Clin Nutr2008871621671:CAS:528:DC%2BD1cXmt1amtg%3D%3D10.1093/ajcn/87.1.162
– reference: KostelacDRechkemmerGBrivibaKPhytoestrogens modulate binding response of estrogen receptors alpha and beta to the estrogen response elementJ Agric Food Chem200351763276351:CAS:528:DC%2BD3sXovVOhtL4%3D10.1021/jf034427b
– reference: NguyenCTPhamNMTranDVLeeAHBinnsCWLifestyle and diet in relation to risk of type 2 diabetes in Vietnam: a hospital-based case-control studySpringerplus2016568710.1186/s40064-016-2313-3
– reference: ZhangMLeeAHBinnsCWPhysical activity and epithelial ovarian cancer risk: a case-control study in ChinaInt J Cancer20031058388431:CAS:528:DC%2BD3sXltVSisb8%3D10.1002/ijc.11165
– reference: TalaeiMLeeBLOngCNvan DamRMYuanJMKohWPUrine phyto-oestrogen metabolites are not significantly associated with risk of type 2 diabetes: the Singapore Chinese health studyBr J Nutr2016115160716151:CAS:528:DC%2BC28XnsFWhs70%3D10.1017/S0007114516000581
– reference: Huong NT, Ward M Vietnam oilseeds and products soybean meal and vegetable oil update. GAIN Report Number: VM5019 (2015).
– reference: TatsumiYMorimotoADeuraKMizunoSOhnoYWatanabeSEffects of soybean product intake on fasting and postload hyperglycemia and type 2 diabetes in Japanese men with high body mass index: The Saku StudyJ Diabetes Investig201346266331:CAS:528:DC%2BC3sXhvVOitL3I10.1111/jdi.12100
– reference: DingMPanAMansonJEWillettWCMalikVRosnerBConsumption of soy foods and isoflavones and risk of type 2 diabetes: a pooled analysis of three US cohortsEur J Clin Nutr201670138113871:CAS:528:DC%2BC28XhtFGjsLzF10.1038/ejcn.2016.117
– reference: KoKPKimCSAhnYParkSJKimYJParkJKPlasma isoflavone concentration is associated with decreased risk of type 2 diabetes in Korean women but not men: results from the Korean Genome and Epidemiology StudyDiabetologia2015587267351:CAS:528:DC%2BC2cXitFOgurfF10.1007/s00125-014-3463-x
– reference: International Diabetes Federation IDF Diabetes Atlas 2015.
– reference: N. C. D. Risk Factor CollaborationWorldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participantsLancet20163871513153010.1016/S0140-6736(16)00618-8
– reference: SetchellKDClericiCEquol: history, chemistry, and formationJ Nutr20101401355S1362S1:CAS:528:DC%2BC3cXot1agtbk%3D10.3945/jn.109.119776
– reference: ChoKWLeeOHBanzWJMoustaid-MoussaNShayNFKimYCDaidzein and the daidzein metabolite, equol, enhance adipocyte differentiation and PPARgamma transcriptional activityJ Nutr Biochem2010218418471:CAS:528:DC%2BC3cXhtVKgsbzK10.1016/j.jnutbio.2009.06.012
– reference: Van TranDVan HoangDNguyenCTLeeAHValidity and reliability of a food frequency questionnaire to assess habitual dietary intake in Northern VietnamVietnam J Pub Health201315764
– reference: YangGShuXOJinFElasyTLiHLLiQSoyfood consumption and risk of glycosuria: a cross-sectional study within the Shanghai Women's Health StudyEur J Clin Nutr2004586156201:STN:280:DC%2BD2c7kvVCrsg%3D%3D10.1038/sj.ejcn.1601855
– reference: BhagwatSHaytowitzDBHoldenJMUSDA Database for the isoflavone Content of Selected Foods Release 2.02008US Department of Agriculture: Maryland
– reference: Zamora-RosRForouhiNGSharpSJGonzalezCABuijsseBGuevaraMThe association between dietary flavonoid and lignan intakes and incident type 2 diabetes in European populations: the EPIC-InterAct studyDiabetes Care201336396139701:CAS:528:DC%2BC3sXhvFaksLrM10.2337/dc13-0877
– reference: WillettWCHoweGRKushiLHAdjustment for total energy intake in epidemiologic studiesAm J Clin Nutr1997651220S1228S1:CAS:528:DyaK2sXitlamu70%3D10.1093/ajcn/65.4.1220S
– reference: MorimotoYSteinbrecherAKolonelLNMaskarinecGSoy consumption is not protective against diabetes in Hawaii: The Multiethnic CohortEur J Clin Nutr2011652792821:STN:280:DC%2BC3M7lvFKgug%3D%3D10.1038/ejcn.2010.228
– reference: ChenLZhangYHHuangTCaiYDGene expression profiling gut microbiota in different races of humansSci Rep20166230751:CAS:528:DC%2BC28XktlKjtL0%3D10.1038/srep23075
– reference: DingELSongYMalikVSLiuSSex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysisJAMA2006295128812991:CAS:528:DC%2BD28Xis1ShsLs%3D10.1001/jama.295.11.1288
– reference: PhamNMEgglestonKDiabetes prevalence and risk factors among Vietnamese adults: findings from community-based screening programsDiabetes Care201538e77e7810.2337/dc14-3093
– reference: Ae ParkSChoiMSChoSYSeoJSJungUJKimMJGenistein and daidzein modulate hepatic glucose and lipid regulating enzyme activities in C57BL/KsJ-db/db miceLife Sci2006791207121310.1016/j.lfs.2006.03.022
– reference: WangLWaltenbergerBPferschy-WenzigEMBlunderMLiuXMalainerCNatural product agonists of peroxisome proliferator-activated receptor gamma (PPARgamma): a reviewBiochem Pharmacol20149273891:CAS:528:DC%2BC2cXht1ymtbjK10.1016/j.bcp.2014.07.018
– reference: MuellerNTOdegaardAOGrossMDKohWPYuMCYuanJMSoy intake and risk of type 2 diabetes in Chinese SingaporeansEur J Nutr201251103310401:CAS:528:DC%2BC38Xhs12is7vN10.1007/s00394-011-0276-2
– reference: RowlandIFaughnanMHoeyLWahalaKWilliamsonGCassidyABioavailability of phyto-oestrogensBr J Nutr200389Suppl 1S45S581:CAS:528:DC%2BD3sXltFentrg%3D12725656
– reference: MuthyalaRSJuYHShengSWilliamsLDDoergeDRKatzenellenbogenBSEquol, a natural estrogenic metabolite from soy isoflavones: convenient preparation and resolution of R- and S-equols and their differing binding and biological activity through estrogen receptors alpha and betaBioorg Med Chem200412155915671:CAS:528:DC%2BD2cXhslSrsb4%3D10.1016/j.bmc.2003.11.035
– reference: DingMFrankeAARosnerBAGiovannucciEvan DamRMTworogerSSUrinary isoflavonoids and risk of type 2 diabetes: a prospective investigation in US womenBr J Nutr2015114169417011:CAS:528:DC%2BC2MXhs1yltLnJ10.1017/S0007114515003359
– reference: EspositoKChiodiniPMaiorinoMIBellastellaGPanagiotakosDGiuglianoDWhich diet for prevention of type 2 diabetes? A meta-analysis of prospective studiesEndocrine2014471071161:CAS:528:DC%2BC2cXmsVCis7c%3D10.1007/s12020-014-0264-4
– reference: NguyenCTPhamNMLeeAHBinnsCWPrevalence of and risk factors for type 2 diabetes mellitus in Vietnam: a systematic reviewAsia Pac J Public Health20152758860010.1177/1010539515595860
– reference: LiJJiaHCaiXZhongHFengQSunagawaSAn integrated catalog of reference genes in the human gut microbiomeNat Biotechnol2014328348411:CAS:528:DC%2BC2cXhtFSlsLjP10.1038/nbt.2942
– reference: Ho-PhamLTDoTTCampbellLVNguyenTVHbA1c-based classification reveals epidemic of diabetes and prediabetes in VietnamDiabetes Care201639e93e9410.2337/dc16-0654
– reference: GreenlandSLashTLBias analysisModern Epidemiology2008Lippincott–Raven: Philadelphia
– reference: OzenAEPonsATurJAWorldwide consumption of functional foods: a systematic reviewNutr Rev20127047248110.1111/j.1753-4887.2012.00492.x
– reference: World Health Organization STEPwise approach to surveillance, 2002. Available at http://www.who.int/chp/steps/en/ (accessed 20 October 2016).
– reference: MurphyPABaruaKHauckCCSolvent extraction selection in the determination of isoflavones in soy foodsJ Chromatogr B Analyt Technol Biomed Life Sci20027771291381:CAS:528:DC%2BD38Xos1Wrtb4%3D10.1016/S1570-0232(02)00342-2
– reference: MessinaMNagataCWuAHEstimated Asian adult soy protein and isoflavone intakesNutr Cancer2006551121:CAS:528:DC%2BD28XhtFakurbP10.1207/s15327914nc5501_1
– reference: The World Health Organization Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia. Report of a WHO/IDF consultation: Geneva, 2006.
– reference: KwonDYDailyJW3rdKimHJParkSAntidiabetic effects of fermented soybean products on type 2 diabetesNutr Res2010301131:CAS:528:DC%2BC3cXhtVKitrs%3D10.1016/j.nutres.2009.11.004
– reference: LiuZMChenYMHoSCEffects of soy intake on glycemic control: a meta-analysis of randomized controlled trialsAm J Clin Nutr201193109211011:CAS:528:DC%2BC3MXltlCqtr0%3D10.3945/ajcn.110.007187
– reference: TalaeiMPanARole of phytoestrogens in prevention and management of type 2 diabetesWorld J Diabetes2015627128310.4239/wjd.v6.i2.271
– reference: InbarajBSChenBHIsoflavone ingestion by multiethnic populations: implications for healthIsoflavones: Chemistry, Analysis, Function and Effects2013RSC Publishing: Cambridge349364
– reference: NanriAMizoueTTakahashiYKiriiKInoueMNodaMSoy product and isoflavone intakes are associated with a lower risk of type 2 diabetes in overweight Japanese womenJ Nutr20101405805861:CAS:528:DC%2BC3cXnsFKhtrk%3D10.3945/jn.109.116020
– reference: SetchellKDPhytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavonesAm J Clin Nutr1998681333S1346S1:CAS:528:DyaK1cXnvV2gsb4%3D10.1093/ajcn/68.6.1333S
– reference: HsiehCCMaisonneuvePBoylePMacfarlaneGJRoberstonCAnalysis of quantitative data by quantiles in epidemiologic studies: classification according to cases, noncases, or all subjects?Epidemiology199121371401:STN:280:DyaK38%2FjtF2muw%3D%3D10.1097/00001648-199103000-00008
– reference: NakamotoMUemuraHSakaiTKatsuura-KamanoSYamaguchiMHiyoshiMInverse association between soya food consumption and insulin resistance in Japanese adultsPublic Health Nutr2015182031204010.1017/S136898001400247X
– reference: LeeSAWenWXiangYBBarnesSLiuDCaiQAssessment of dietary isoflavone intake among middle-aged Chinese menJ Nutr20071371011101610.1093/jn/137.4.1011
– reference: OrsiniNBelloccoRA tool for deterministic and probabilistic sensitivity analysis of epidemiologic studiesStat J20088294810.1177/1536867X0800800103
– reference: JamesPAOparilSCarterBLCushmanWCDennison-HimmelfarbCHandlerJ2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)JAMA20143115075201:CAS:528:DC%2BC2cXis1aktr8%3D10.1001/jama.2013.284427
– reference: DurrlemanSSimonRFlexible regression models with cubic splinesStat Med198985515611:STN:280:DyaL1M3ms1artg%3D%3D10.1002/sim.4780080504
– volume: 387
  start-page: 1513
  year: 2016
  ident: BFejcn201776_CR2
  publication-title: Lancet
  doi: 10.1016/S0140-6736(16)00618-8
– start-page: 349
  volume-title: Isoflavones: Chemistry, Analysis, Function and Effects
  year: 2013
  ident: BFejcn201776_CR18
– volume: 6
  start-page: 23075
  year: 2016
  ident: BFejcn201776_CR40
  publication-title: Sci Rep
  doi: 10.1038/srep23075
– volume: 8
  start-page: 551
  year: 1989
  ident: BFejcn201776_CR31
  publication-title: Stat Med
  doi: 10.1002/sim.4780080504
– volume: 39
  start-page: e93
  year: 2016
  ident: BFejcn201776_CR50
  publication-title: Diabetes Care
  doi: 10.2337/dc16-0654
– ident: BFejcn201776_CR1
– volume: 21
  start-page: 841
  year: 2010
  ident: BFejcn201776_CR8
  publication-title: J Nutr Biochem
  doi: 10.1016/j.jnutbio.2009.06.012
– volume: 12
  start-page: 1559
  year: 2004
  ident: BFejcn201776_CR46
  publication-title: Bioorg Med Chem
  doi: 10.1016/j.bmc.2003.11.035
– volume: 140
  start-page: 580
  year: 2010
  ident: BFejcn201776_CR10
  publication-title: J Nutr
  doi: 10.3945/jn.109.116020
– ident: BFejcn201776_CR23
– volume: 47
  start-page: 107
  year: 2014
  ident: BFejcn201776_CR3
  publication-title: Endocrine
  doi: 10.1007/s12020-014-0264-4
– volume: 6
  start-page: 271
  year: 2015
  ident: BFejcn201776_CR6
  publication-title: World J Diabetes
  doi: 10.4239/wjd.v6.i2.271
– volume: 1
  start-page: 57
  year: 2013
  ident: BFejcn201776_CR24
  publication-title: Vietnam J Pub Health
– volume: 58
  start-page: 726
  year: 2015
  ident: BFejcn201776_CR32
  publication-title: Diabetologia
  doi: 10.1007/s00125-014-3463-x
– volume: 65
  start-page: 1220S
  year: 1997
  ident: BFejcn201776_CR26
  publication-title: Am J Clin Nutr
  doi: 10.1093/ajcn/65.4.1220S
– volume: 58
  start-page: 615
  year: 2004
  ident: BFejcn201776_CR33
  publication-title: Eur J Clin Nutr
  doi: 10.1038/sj.ejcn.1601855
– volume: 5
  start-page: 687
  year: 2016
  ident: BFejcn201776_CR22
  publication-title: Springerplus
  doi: 10.1186/s40064-016-2313-3
– volume: 311
  start-page: 507
  year: 2014
  ident: BFejcn201776_CR29
  publication-title: JAMA
  doi: 10.1001/jama.2013.284427
– volume: 32
  start-page: 834
  year: 2014
  ident: BFejcn201776_CR41
  publication-title: Nat Biotechnol
  doi: 10.1038/nbt.2942
– ident: BFejcn201776_CR28
– volume: 115
  start-page: 1607
  year: 2016
  ident: BFejcn201776_CR35
  publication-title: Br J Nutr
  doi: 10.1017/S0007114516000581
– volume: 114
  start-page: 1694
  year: 2015
  ident: BFejcn201776_CR16
  publication-title: Br J Nutr
  doi: 10.1017/S0007114515003359
– volume: 89
  start-page: S45
  issue: Suppl 1
  year: 2003
  ident: BFejcn201776_CR39
  publication-title: Br J Nutr
  doi: 10.1079/BJN2002796
– volume: 92
  start-page: 73
  year: 2014
  ident: BFejcn201776_CR44
  publication-title: Biochem Pharmacol
  doi: 10.1016/j.bcp.2014.07.018
– volume: 79
  start-page: 1207
  year: 2006
  ident: BFejcn201776_CR43
  publication-title: Life Sci
  doi: 10.1016/j.lfs.2006.03.022
– volume: 70
  start-page: 1381
  year: 2016
  ident: BFejcn201776_CR14
  publication-title: Eur J Clin Nutr
  doi: 10.1038/ejcn.2016.117
– volume: 137
  start-page: 1011
  year: 2007
  ident: BFejcn201776_CR37
  publication-title: J Nutr
  doi: 10.1093/jn/137.4.1011
– volume: 65
  start-page: 279
  year: 2011
  ident: BFejcn201776_CR13
  publication-title: Eur J Clin Nutr
  doi: 10.1038/ejcn.2010.228
– volume: 70
  start-page: 472
  year: 2012
  ident: BFejcn201776_CR17
  publication-title: Nutr Rev
  doi: 10.1111/j.1753-4887.2012.00492.x
– volume-title: USDA Database for the isoflavone Content of Selected Foods Release 2.0
  year: 2008
  ident: BFejcn201776_CR25
– volume: 55
  start-page: 1
  year: 2006
  ident: BFejcn201776_CR5
  publication-title: Nutr Cancer
  doi: 10.1207/s15327914nc5501_1
– volume: 295
  start-page: 1288
  year: 2006
  ident: BFejcn201776_CR47
  publication-title: JAMA
  doi: 10.1001/jama.295.11.1288
– volume: 4
  start-page: 626
  year: 2013
  ident: BFejcn201776_CR12
  publication-title: J Diabetes Investig
  doi: 10.1111/jdi.12100
– volume: 140
  start-page: 1355S
  year: 2010
  ident: BFejcn201776_CR42
  publication-title: J Nutr
  doi: 10.3945/jn.109.119776
– volume: 38
  start-page: e77
  year: 2015
  ident: BFejcn201776_CR20
  publication-title: Diabetes Care
  doi: 10.2337/dc14-3093
– volume: 51
  start-page: 7632
  year: 2003
  ident: BFejcn201776_CR45
  publication-title: J Agric Food Chem
  doi: 10.1021/jf034427b
– ident: BFejcn201776_CR21
– volume: 2
  start-page: 137
  year: 1991
  ident: BFejcn201776_CR30
  publication-title: Epidemiology
  doi: 10.1097/00001648-199103000-00008
– volume: 18
  start-page: 2031
  year: 2015
  ident: BFejcn201776_CR34
  publication-title: Public Health Nutr
  doi: 10.1017/S136898001400247X
– volume: 93
  start-page: 1092
  year: 2011
  ident: BFejcn201776_CR36
  publication-title: Am J Clin Nutr
  doi: 10.3945/ajcn.110.007187
– volume: 30
  start-page: 1
  year: 2010
  ident: BFejcn201776_CR7
  publication-title: Nutr Res
  doi: 10.1016/j.nutres.2009.11.004
– volume: 51
  start-page: 1033
  year: 2012
  ident: BFejcn201776_CR11
  publication-title: Eur J Nutr
  doi: 10.1007/s00394-011-0276-2
– volume: 105
  start-page: 838
  year: 2003
  ident: BFejcn201776_CR27
  publication-title: Int J Cancer
  doi: 10.1002/ijc.11165
– volume: 777
  start-page: 129
  year: 2002
  ident: BFejcn201776_CR4
  publication-title: J Chromatogr B Analyt Technol Biomed Life Sci
  doi: 10.1016/S1570-0232(02)00342-2
– volume: 87
  start-page: 162
  year: 2008
  ident: BFejcn201776_CR9
  publication-title: Am J Clin Nutr
  doi: 10.1093/ajcn/87.1.162
– volume: 36
  start-page: 3961
  year: 2013
  ident: BFejcn201776_CR15
  publication-title: Diabetes Care
  doi: 10.2337/dc13-0877
– volume: 27
  start-page: 588
  year: 2015
  ident: BFejcn201776_CR19
  publication-title: Asia Pac J Public Health
  doi: 10.1177/1010539515595860
– volume-title: Modern Epidemiology
  year: 2008
  ident: BFejcn201776_CR48
– volume: 8
  start-page: 29
  year: 2008
  ident: BFejcn201776_CR49
  publication-title: Stat J
  doi: 10.1177/1536867X0800800103
– volume: 68
  start-page: 1333S
  year: 1998
  ident: BFejcn201776_CR38
  publication-title: Am J Clin Nutr
  doi: 10.1093/ajcn/68.6.1333S
SSID ssj0014772
Score 2.3627567
Snippet Background/Objectives: Animal studies have demonstrated that soy isoflavones exert antidiabetic effects. However, evidence regarding the association between...
Animal studies have demonstrated that soy isoflavones exert antidiabetic effects. However, evidence regarding the association between soyfood intake, a unique...
Background/Objectives: Animal studies have demonstrated that soy isoflavones exert antidiabetic effects. However, evidence regarding the association between...
Background/Objectives:Animal studies have demonstrated that soy isoflavones exert antidiabetic effects. However, evidence regarding the association between...
SourceID proquest
gale
pubmed
crossref
springer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1186
SubjectTerms 692/499
692/699/2743/137/773
Adult
Adults
Aged
Antidiabetics
Asian people
Beansprouts
Case-Control Studies
Clinical Nutrition
Confidence intervals
Control methods
Daidzein
Demographics
Demography
Diabetes
Diabetes mellitus
Diabetes mellitus (non-insulin dependent)
Diabetes Mellitus, Type 2 - epidemiology
Diabetes Mellitus, Type 2 - etiology
Diabetes Mellitus, Type 2 - prevention & control
Disease prevention
Epidemiology
Feeding Behavior
Female
Genistein
Glycine max
Health aspects
Health risk assessment
Health risks
Hospitals
Humans
Internal Medicine
Isoflavones
Isoflavones - administration & dosage
Isoflavones - blood
Male
Medicine
Medicine & Public Health
Metabolic Diseases
Middle Aged
Nutrition research
original-article
Plant-based beverages
Polyphenols
Public Health
Regression analysis
Risk
Risk Factors
Soy products
Soybean milk
Soybean products
Soybeans
Statistical analysis
Surveys and Questionnaires
Tofu
Type 2 diabetes
Vietnam - epidemiology
Title Soyfood and isoflavone intake and risk of type 2 diabetes in Vietnamese adults
URI https://link.springer.com/article/10.1038/ejcn.2017.76
https://www.ncbi.nlm.nih.gov/pubmed/28488690
https://www.proquest.com/docview/1946274166
https://www.proquest.com/docview/2615533833
https://www.proquest.com/docview/1899103678
Volume 71
WOSCitedRecordID wos000412202800007&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVPQU
  databaseName: Agricultural Science Database
  customDbUrl:
  eissn: 1476-5640
  dateEnd: 20171231
  omitProxy: false
  ssIdentifier: ssj0014772
  issn: 0954-3007
  databaseCode: M0K
  dateStart: 19970201
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/agriculturejournals
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Biological Science Database
  customDbUrl:
  eissn: 1476-5640
  dateEnd: 20171231
  omitProxy: false
  ssIdentifier: ssj0014772
  issn: 0954-3007
  databaseCode: M7P
  dateStart: 19970201
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/biologicalscijournals
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Nursing & Allied Health Database
  customDbUrl:
  eissn: 1476-5640
  dateEnd: 20171231
  omitProxy: false
  ssIdentifier: ssj0014772
  issn: 0954-3007
  databaseCode: 7RV
  dateStart: 19970201
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/nahs
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 1476-5640
  dateEnd: 20171231
  omitProxy: false
  ssIdentifier: ssj0014772
  issn: 0954-3007
  databaseCode: BENPR
  dateStart: 19970201
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Health & Medical Collection
  customDbUrl:
  eissn: 1476-5640
  dateEnd: 20171231
  omitProxy: false
  ssIdentifier: ssj0014772
  issn: 0954-3007
  databaseCode: 7X7
  dateStart: 19970201
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Research Library
  customDbUrl:
  eissn: 1476-5640
  dateEnd: 20171231
  omitProxy: false
  ssIdentifier: ssj0014772
  issn: 0954-3007
  databaseCode: M2O
  dateStart: 19970201
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/pqrl
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Public Health Database
  customDbUrl:
  eissn: 1476-5640
  dateEnd: 20171231
  omitProxy: false
  ssIdentifier: ssj0014772
  issn: 0954-3007
  databaseCode: 8C1
  dateStart: 19970201
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/publichealth
  providerName: ProQuest
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELZoy4ELj5ZHoCxGgnJAaZM4ieMTWkorJCCsClR7i_xI0MKSlGZbqf-eGedBttqWAxdLG89OHI09nvGMvyHkRaxUAF5C4TJhhBuCDeAKw7SrjGAxXvWR2lYt-cjTNJlOxaQ9cKvbtMpOJ1pFbSqNZ-R7AQbQ0J9ib05-u1g1CqOrbQmNNbKBKAnMpu5N-ihCyG3xJrAi8PTf423iu8eSvfyHRvRTn-8i2shgS7qsmAc706VQqd2BDu_879jvktut7UnHzWS5R27k5SbZGpfgd_-6oDvUZoPaY_ZN4ryb5Qt41uKGzmnawfZvkfRLdVFUlaGyNHRWV8VcnldlTmflQv7M7VPMWKdVQfGElwa0O-EFEnoMjEvMzQVKBP-o75Nvhwdf99-7bV0GV_OALVwJLl1gDUWttNahVHGI4UdfFVIVeRDIQAmfFSrUioF7EyutolgkoWGRFmAvPSDrJQzrEaFM-4oLMHtUaEKjufRMmPPIeNKoRInIIa870WS6BS3H2hnzzAbPWZKhIDMUZMZjh7zsqU8asI4r6J6hlLPmqmm_xrNxhHCBwhPelRRxIhDyLwIerywF6gEYkZbtdQb4LkTUWuL1D8oBz50lyu8N8vgqltcTDjhuLxGC7tBLfFZ1D__dzeesVW115ovQ1muKV3f_nesOed53I2PM5ivz6gxYgJMPQgE7ySEPm9XVywvMpQSrpMEndstt8O4Vwnx8_SiekFtI2ORfbpP1xelZ_pTc1OeLWX06Imv86BjbKbdtAm2y74_IxtuDdHIEvz55H7ANPo-sbvkDCGl3Fg
linkProvider ProQuest
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1R1dT9RAcINoIi9-gB9VlDURfCCVttt2uw_GXEQC4bwYRcJb3Y-WnJ4tcgVzf8rf6My2PXvkwCcefO1Op7vd-dyZnSHkZaxUAF5C7jJhhBuCDeAKw7SrjGAxXvWR2nYt6fPBIDk6Eh8XyO_2LgymVbYy0QpqU2o8I98KMICG_hR7e_LTxa5RGF1tW2jUZLGfTX6ByzZ-s7cN-7seBDvvD97tuk1XAVfzgFWuBIcksGaOVlrrUKo4xOCZr3Kp8iwIZKCEz3IVasXAOI-VVlEsktCwSAvQ9oD3BrkJctzHFDL-6XAatQi5bRYFVgtGGzzeJNp7LNnKvmmsturz11jdpKMCLyqCjia8EJq1Gm_n7v_2r-6RO41tTXs1M9wnC1mxTFZ6hazKHxO6QW22qw0jLBNne5hV8Kypizqig7YtwQoZfC4neVkaKgtDh-MyH8nzssjosKjk98w-xYx8WuYUT7BpQNsTbAChh4C4wNxjgMTiJuMH5Mu1rPohWSxgWo8JZdpXXIBZp0ITGs2lZ8KMR8aTRiVKRA7ZbEkh1U1RduwNMkptcgBLUiScFAkn5bFD1qfQJ3Uxkkvg1pCq0voq7VSGpb0IyyEKT3iXQsSJwJKGEeB4ZSFQzsGMtGyua8C6sGLYDK5_QHZwbsxAHteV1eehvBqwg3F1BhBko57BM2-4-3bLP2kjusepL0LbjyqeP_yXtxzyYjqMiDFbscjKM0CRgNcFpiFPHPKo5ubpfoE5mGAXOFhiy96db8_ZzCdXz2KN3N49-NBP-3uD_adkCV-qc01XyWJ1epY9I7f0eTUcnz63soqSr9fN8H8AGFDNJg
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1R3LbtQw0CoFIS48Wh6BQo1EywGFTeIkjg8IrbqsqFqtKvFQb8GPpNqyJKWbFu2v8XXMOMmSrbbl1APXeDKx45nxjOdFyKtYqQCshNxlwgg3BB3AFYZpVxnBYkz1kdp2Ldnno1FyeCgOVsjvNhcGwypbmWgFtSk13pH3AnSgoT3FenkTFnEwGL4_-eliByn0tLbtNGoS2ctmv8B8m77bHcBebwXB8MPnnY9u02HA1TxglSvBOAmsyqOV1jqUKg7RkearXKo8CwIZKOGzXIVaMVDUY6VVFIskNCzSAk5-wHuD3OQMqBiz1Hfm4SV-yG3jKNBg0PPg8Sbo3mNJLzvWWHnV52-x0knnOLx4KHROxQtuWnv6De_9z__tPrnb6Ny0XzPJA7KSFWtkvV_Iqvwxo9vURsFa98IacQbjrIJnTb3UCR217QrWyehTOcvL0lBZGDqelvlEnpdFRsdFJb9n9ilG6tMyp3izTQPa3mwDCP0KiAuMSQZILHoyfUi-XMuqH5HVAqb1hFCmfcUFqHsqNKHRXHomzHhkPGlUokTkkDctWaS6KdaOPUMmqQ0aYEmKRJQiEaU8dsjWHPqkLlJyCdwmUlhap9jOZVvaj7BMovCEdylEnAgsdRgBjtcWAuUfzEjLJo0D1oWVxBZw_QOyg3N7AfKorri-DOXVgB2MGwuAIDP1Ap5lw923W15KG5E-TX0R2j5V8fLhv3zmkJfzYUSMUYxFVp4BigSsMVAZeeKQxzVnz_cL1MQEu8PBEltW73x7yWY-vXoWm-Q28Hm6vzvae0bu4Dt1COoGWa1Oz7Ln5JY-r8bT0xdWbFHy7br5_Q_pwNWB
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Soyfood+and+isoflavone+intake+and+risk+of+type+2+diabetes+in+Vietnamese+adults&rft.jtitle=European+journal+of+clinical+nutrition&rft.au=Lee%2C+A+H&rft.au=Nguyen%2C+C+T&rft.au=Hoang%2C+V+M&rft.au=Do%2C+V+V&rft.date=2017-10-01&rft.pub=Nature+Publishing+Group&rft.issn=0954-3007&rft.volume=71&rft.issue=10&rft.spage=1186&rft_id=info:doi/10.1038%2Fejcn.2017.76&rft.externalDBID=n%2Fa&rft.externalDocID=A507939090
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0954-3007&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0954-3007&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0954-3007&client=summon